Meridian Bioscience Inc. (VIVO) financial statements (2021 and earlier)

Company profile

Business Address 3471 RIVER HILLS DR
CINCINNATI, OH 45244
State of Incorp. OH
Fiscal Year End September 30
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments69626057475043
Cash and cash equivalents69626057475043
Receivables35363229272623
Inventory, net of allowances, customer advances and progress billings43404241453635
Inventory43404241453635
Prepaid expense      7
Other undisclosed current assets67567114
Total current assets:152145139134127123113
Noncurrent Assets
Property, plant and equipment30313031302728
Intangible assets, net (including goodwill)   82922831
Goodwill   55622223
Intangible assets, net (excluding goodwill)   273068
Derivative instruments and hedges   1   
Restricted cash and investments   1111
Other noncurrent assets155150820000
Other undisclosed noncurrent assets   2134
Total noncurrent assets:1861811121161256064
TOTAL ASSETS:338325251250252183177
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20211916191514
Accounts payable8768875
Accrued liabilities3453333
Employee-related liabilities6875755
Taxes payable2201111
Interest and dividends payable1      
Debt1 554  
Business combination, contingent consideration, liability14  2   
Total current liabilities:35212423231514
Noncurrent Liabilities
Long-term debt and lease obligation8076455055  
Long-term debt, excluding current maturities7676455055  
Operating lease, liability4 
Liabilities, other than long-term debt2037667  
Accounts payable and accrued liabilities110    
Deferred tax liabilities, net443  
Deferred income tax liabilities 2
Liability, pension and other postretirement and postemployment benefits 2222  
Business combination, contingent consideration, liability2032 02  
Derivative instruments and hedges, liabilities    1  
Other undisclosed noncurrent liabilities5111122
Total noncurrent liabilities:10611452576322
Total liabilities:1411357680851716
Stockholders' equity
Stockholders' equity attributable to parent197191175170166166161
Additional paid in capital134133129126122117112
Accumulated other comprehensive income (loss)(2)(5)(3)(3)(6)(2)0
Retained earnings66635047505149
Total stockholders' equity:197191175170166166161
TOTAL LIABILITIES AND EQUITY:338325251250252183177

Income statement (P&L) ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Revenues197201214201196195189
Revenue, net201196195189
Cost of revenue
(Cost of Goods and Services Sold)
(83)(83)(83)(76)(68)(73)(72)
Gross profit:114118130125128122117
Operating expenses(87)(86)(99)(87)(76)(66)(65)
Operating income:28333237515652
Nonoperating expense(2)(1)(1)(1)(1)(1)(0)
Investment income, nonoperating1100000
Foreign currency transaction loss, before tax     (1) 
Other nonoperating income (expense)(1)0(0)10(1)(0)
Interest and debt expense(2)(2)(2)(2)(1)  
Income from continuing operations before equity method investments, income taxes:23302935505552
Other undisclosed income from continuing operations before income taxes22221  
Income from continuing operations before income taxes:25323036515552
Income tax expense(6)(7)(7)(15)(18)(20)(17)
Net income available to common stockholders, diluted:19242422323635

Comprehensive Income ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Net income:19242422323635
Comprehensive income:19242422323635
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2(2)(0)3(3)(3)(0)
Comprehensive income, net of tax, attributable to parent:21232324293334

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: